Fábio Fiúza Rosa

Fábio Fiúza Rosa has a diverse work experience in the field of research and academia. Fábio is currently working at Asgard Therapeutics as the Head of Research and a Co-founder and Board Observer. Fábio has been with the company since November 2021. Prior to this, Fábio was a Co-Founder and Board Member at Asgard Therapeutics from December 2018 to October 2021.

Before joining Asgard Therapeutics, Fábio worked as a PhD Student at CNC UC from September 2017 to October 2021. Fábio also worked as a PhD Student at Lunds universitet from January 2018 to June 2021.

Fábio's experience also includes being a Co-Founder and Board Member at BRT Blood Reprogramming Technologies Lda in March 2017. Additionally, they have worked as an MSc student in Biochemistry at Universidade de Coimbra from September 2014 to September 2016.

Overall, Fábio has gained significant experience in research and academia through their various roles in different organizations.

Fábio Fiúza Rosa pursued their education in the field of Biomedicine, starting in 2018 and completing it in 2021 at Lund University, where they obtained a Ph.D. degree. Prior to this, from 2011 to 2014, Fábio attended Universidade de Coimbra, where they earned a Licenciado em Biologia degree with a specialization in Bioquímica.